Free tool
FAERS Monitor: Clinimix 8/14 Sulfite Free In Dextrose 14% In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020734 or its brand name (Clinimix 8/14 Sulfite Free In Dextrose 14% In Plastic Container, Amino Acids, Dextrose). Reports on generic versions are filed under their own applications.
Reports
66
Serious
42
64% of reports
Hospitalization
23
Death reported
14
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- pyrexia9
- erythema6
- nausea6
- stevens-johnson syndrome5
- wrong technique in drug usage process5
- blister4
- general physical health deterioration4
- lip erosion4
- malaise4
- medication error4
- no adverse event4
- abdominal pain3
- blood glucose increased3
- diarrhoea3
- extravasation3
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 6 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 10 |
| 2022 | 7 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 2 |
| 2026 | 2 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,093 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| lip erosionSignal | 4 | 1757.6 | 678.0 | 5,346 |
| extravasationSignal | 3 | 232.8 | 77.0 | 480 |
| stevens-johnson syndromeSignal | 5 | 71.7 | 30.8 | 282 |
| wrong technique in drug usage processSignal | 5 | 43.9 | 18.9 | 169 |
| medication errorSignal | 4 | 22.9 | 8.9 | 64 |
| blisterSignal | 4 | 22.7 | 8.8 | 63 |
| general physical health deteriorationSignal | 4 | 11.0 | 4.3 | 27 |
| erythemaSignal | 6 | 9.3 | 4.3 | 37 |
| pyrexiaSignal | 9 | 8.3 | 4.5 | 51 |
| no adverse eventSignal | 4 | 7.0 | 2.7 | 15 |
| blood glucose increasedSignal | 3 | 5.1 | 1.7 | 6 |
| abdominal painSignal | 3 | 4.1 | 1.4 | 4 |
| malaise | 4 | 2.9 | 1.1 | 3 |
| nausea | 6 | 2.4 | 1.1 | 4 |
| diarrhoea | 3 | 1.5 | 0.5 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.